1. Home
  2. PIPR vs TXG Comparison

PIPR vs TXG Comparison

Compare PIPR & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Piper Sandler Companies

PIPR

Piper Sandler Companies

HOLD

Current Price

$77.31

Market Cap

4.9B

Sector

Finance

ML Signal

HOLD

Logo 10x Genomics Inc.

TXG

10x Genomics Inc.

HOLD

Current Price

$47.12

Market Cap

5.6B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
PIPR
TXG
Founded
1895
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Laboratory Analytical Instruments
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
5.6B
IPO Year
2003
2019

Fundamental Metrics

Financial Performance
Metric
PIPR
TXG
Price
$77.31
$47.12
Analyst Decision
Buy
Hold
Analyst Count
3
15
Target Price
$91.38
$20.25
AVG Volume (30 Days)
592.2K
3.2M
Earning Date
05-01-2026
05-07-2026
Dividend Yield
2.26%
N/A
EPS Growth
54.49
76.97
EPS
0.92
N/A
Revenue
$1,904,217,000.00
$245,893,000.00
Revenue This Year
$12.30
N/A
Revenue Next Year
$13.55
$7.33
P/E Ratio
$82.77
N/A
Revenue Growth
24.33
68.06
52 Week Low
$70.27
$11.17
52 Week High
$380.26
$46.32

Technical Indicators

Market Signals
Indicator
PIPR
TXG
Relative Strength Index (RSI) 52.06 70.52
Support Level $75.40 $16.11
Resistance Level $82.43 N/A
Average True Range (ATR) 2.44 2.79
MACD 0.81 0.12
Stochastic Oscillator 90.33 98.46

Price Performance

Historical Comparison
PIPR
TXG

About PIPR Piper Sandler Companies

Piper Sandler Cos is an investment bank and institutional securities firm, serving the needs of corporations, private equity groups, public entities, non-profit entities, and institutional investors in the United States (U.S.) and internationally. The company provides a broad set of products and services, including financial advisory services; equity and debt capital markets products; public finance services; institutional brokerage services; fundamental equity and macro research services; fixed income services; and alternative asset management strategies. It generates maximum revenue from Advisory services.

About TXG 10x Genomics Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

Share on Social Networks: